Elevated Interleukin-18 Levels Are Associated With the Metabolic Syndrome Independent of Obesity and Insulin Resistance

Keywords

Metabolic syndrome, Insulin resistance, Internal medicine, Endocrinology, Hyperinsulinemia

References

• Interleukin-18: a novel cytokine that augments both innate and acquired immunity.Haruki Okamura, Hiroko Tsutsui, Shin‐ichiro Kashiwamura — 1998
• Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects.Jean‐Philippe Bastard, Claude Jardel, Jacques Delattre — 1999
• Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal womenHéctor F. Escobar‐Morreale, Gemma Villuendas, José I. Botella‐Carretero — 2003
• How good a marker is insulin level for insulin resistance?Markku Laakso — 1993
• Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes.John C. Pickup — 2004
• Angiotensin-converting enzyme gene polymorphism and carotid wall thickening in a community population.Joseph Hung, B. McQuillan, Mark Nidorf — 1999
• Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "minimal model". Insulin Resistance Atherosclerosis Study (IRAS) Investigators.George Howard, Richard N. Bergman, Lynne E. Wagenknecht — 1998
• Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).Andreas Festa, Ralph B. D’Agostino, George Howard — 2000
• C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.Aruna D. Pradhan — 2001
• Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity.Héctor F. Escobar‐Morreale, José I. Botella‐Carretero, Gemma Villuendas — 2004
• Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome.Pamela A. Sakkinen, Patricia Wahl, Mary Cushman — 2000
• Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes.Yoshimasa Aso, Ki-ichi Okumura, Kohzo Takebayashi — 2003
• Association between C-reactive protein and features of the metabolic syndrome: a population-based study.Margit Fröhlich, Armin Imhof, G Berg — 2000
• Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS)B. McQuillan, John Beilby, Mark Nidorf — 1999
• C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.John Danesh, Jeremy G. Wheeler, Gideon M. Hirschfield — 2004
• The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.Hanna‐Maaria Lakka — 2002
• Atherothrombosis, inflammation, and diabetes.Giuseppe Biondi‐Zoccai, Antonio Abbate, Giovanna Liuzzo — 2003
• C-Reactive Protein Is Independently Associated With Fasting Insulin in Nondiabetic WomenAruna D. Pradhan, Nancy R. Cook, Julie E. Buring — 2003
• Interleukin-18 Is a Strong Predictor of Cardiovascular Death in Stable and Unstable AnginaStefan Blankenberg, Laurence Tiret, Christoph Bickel — 2002
• Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque InstabilityZiad Mallat, Anne Corbaz, Alexandra Scoazec — 2001

Cited by

• Effects of lifestyle interventions on inflammatory markers in the metabolic syndromeKristen M. Beavers — 2011
• Elevation of plasma interleukin-18 concentration is associated with insulin levels in patients with systemic lupus erythematosusJosé García Santesmases, Antonio Vaquero Sánchez, José María Guillén Rubio — 2006
• Maternal nutrient restriction during early fetal kidney development attenuates the renal innate inflammatory response in obese young adult offspring.健吾 川崎, 智也 大西, 博敏 坂井 — 2009
• Effect of the mediterranean diet with and without weight loss on markers of inflammation in men with metabolic syndromeJordan M. Poss — 2012
• Association Between Metabolic Syndrome and Osteoporotic Fracture in Middle-aged and Elderly Chinese Peoples高冠男 — 2014
• Metabolic syndrome and osteoporotic fracture: a population-based study in ChinaG.U. Dinneen — 2016
• The modern interleukin-1 superfamily: Divergent roles in obesity.Eliza Pennypacker, Stuart Echols — 2016
• Interleukin-18 polymorphism as an inflammatory index in metabolic syndrome: A preliminary studyPhilippe Lamarche — 2017
• Inflammation in type 2 diabetes and the neuroendocrine role of IL-18Chris Booker — 2013
• Interleukin-18 levels are not associated with subclinical carotid atherosclerosis in a community population. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).Caroline Chapman, B. McQuillan, John Beilby — 2006
• Unraveling the Role of Epigenetics in Aging and Chronic Disease.Alicia L. Zagel — 2013
• Interleukin 18 and cardiovascular disease in HIV-1 infection: a partner in crime?Donato Torre, Agostino Pugliese — 2010
• The Potential Roles of Superoxide Dismutase, Matrix-Metalloprotinase-9 and Interlukine -18 with the Prevalence and Progression of Type II Diabetes MellitusShwan Ali Umar — 2015
• The role of IL-18 in cross-susceptibility between periodontal disease and diabetesP. Jitprasertwong — 2011
• RETRACTED ARTICLE: Significance of Increased Serum Interleukin-18 Levels in Stroke Patients: A Meta-AnalysisYong-Shun Hao, Q. Hu, Xiao-Jie Zhang — 2015
• The role of adipose tissue in endocrine and metabolic diseases: studies in men and miceTim B. Koenen — 2011
• CARDIOVASCULAR RISK AND STRESS ADAPTATION IN METABOLIC DISEASESMárta Sárközy — 2013
• Effect of resistance training on serum interleukin-18 and C-reactive protein in obese men.Farhad Kouhi, Fatah Moradi, M. Absazadegan — 2014
• Riesgo cardiovascular en el adolescente obeso: reversibilidad clínica, metabólica y de la pared vascular tras una intervenciónN. Miró — 2010
• Síndrome de Prader-Willi como modelo de obesidad: Ghrelina, péptido YY, adiponectina y parámetros inflamatoriosOlga Giménez Palop — 2007

Related papers

• Resistance to metabolic actions of insulin and its role in hypertension.John E. Hall, Richard L. Summers, Michael W. Brands — 1994
• Molecular mechanisms of insulin resistance that impact cardiovascular biology.Cecilia C. Low Wang, Marc L. Goalstone, Boris Draznin — 2004
• [Hypertension and insulin resistance in obese type 2 diabetic Wistar fatty rat].Masami Suzuki, Hiroyuki Odaka — 2003
• Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer’s Disease?Vijay Hegde, Nikhil V. Dhurandhar, P. Hemachandra Reddy — 2019
• [Pathogenesis of atherosclerosis in diabetes mellitus. The role of insulin resistance and hyperinsulinemia].E p Kostiuk, С. Т. Зубкова — 1993
• Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease?Gerald M. Reaven, Philip S. Tsao — 2003
• High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndromePamela J. Goodwin, Marguerite Ennis, Mala Bahl — 2009
• Insulin resistance and coronary heart disease in nondiabetic individuals.Gerald M. Reaven — 2012
• Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.Reaven Gm — 2005
• Is Homeostasis Model Assessment Better Than the Quantitative Insulin-Sensitivity Check Index and Fasting Glucose/Insulin Ratio?: In ReplyMehmet Zeynel Keskin — 2005